The Iridium‐Catalyzed Synthesis of Symmetrically and Unsymmetrically Alkylated Diamines under Mild Reaction Conditions

An iridium catalyst – stabilized by an anionic P,N ligand – was used for the symmetrical and unsymmetrical monoalkylation of para‐, meta‐, and ortho‐benzenediamines. Benzyl and aliphatic alcohols were used as alkylating reagents. 28 derivatives were synthesized. 14 of them are new compounds. Furthermore, the alkylation of the pharmacological important diamine Dapson^® (dapsone) is described. 14 dapsone derivatives were synthesized among them 9 new compounds.     

Nicotine as a conditioned stimulus: Impact of attention-deficit/hyperactivity disorder medications.

People diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk to start smoking and have greater difficulty quitting. Nicotine, one of the principal addictive components of tobacco smoke, functioned as a conditioned stimulus (CS) for intermittent sucrose delivery in a Pavlovian drug discrimination task with rats. This study compared the ability of commonly prescribed ADHD medications (i.e., methylphenidate, atomoxetine, and bupropion) and additional dopamine reuptake inhibitors (i.e., cocaine and GBR 12909) to substitute for the CS effects of nicotine. Atomoxetine was also used to antagonize these CS effects. Rats acquired the discrimination as evidenced by increased dipper entries in nicotine (0.2 mg base/kg) sessions as compared with saline sessions. Nicotine generalization was dose dependent. Bupropion (10 and 20 mg/kg), methylphenidate (10 mg/kg), and cocaine (5 and 10 mg/kg) partially substituted for the 0.2 mg/kg nicotine CS. Atomoxetine did not substitute for the nicotine CS; however, atomoxetine (1 to 10 mg/kg) partially blocked nicotine's CS effects. These results suggest that atomoxetine, bupropion, and/or methylphenidate may be effective treatments for people diagnosed with ADHD and addicted to nicotine. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Cooperative Activation in the Hydrolytic Kinetic Resolution of Epoxides by a Bis‐Cobalt(III)salen‐Calix[4]arene Hybrid

A chiral, bimetallic cobalt(III)salen‐calix[4]arene hybrid structure was prepared and tested in the hydrolytic kinetic resolution (HKR) of racemic epoxides. Kinetic studies have revealed that the two catalytic units on the upper rim of the calixarene scaffold are able to activate the reactants in a cooperative and primarily intramolecular mode. High enantioselective behaviour was observed and besides, a higher stability was found for the bimetallic catalyst as compared to a monometallic reference complex.     

Radiofluorinated Pyrimidine‐2,4,6‐triones as Molecular Probes for Noninvasive MMP‐Targeted Imaging

Matrix metalloproteinases (MMPs) are zinc‐ and calcium‐dependent endopeptidases. Representing a subfamily of the metzincin superfamily, MMPs are involved in the proteolytic degradation of components of the extracellular matrix. Unregulated MMP expression, MMP dysregulation and locally increased MMP activity are common features of various diseases, such as cancer, atherosclerosis, stroke, arthritis, and others. Therefore, activated MMPs are suitable biological targets for the specific visualization of such pathologies, in particular by using radiolabeled MMP inhibitors (MMPIs). The aim of this work was to develop a radiofluorinated molecular probe for noninvasive in vivo imaging for the detection of up‐regulated levels of activated MMPs in the living organism. Fluorinated MMPIs ( 26 , 31 and 38 ) based on the pyrimidine‐2,4,6‐trione lead structure RO 28‐2653 ( 1 ) were synthesized, and their MMP inhibition potency was evaluated in vitro. The radiosynthesis and the in vivo biodistribution of the first ¹⁸F‐labeled prototype, MMP‐targeted tracer [¹⁸F] 26 , suitable for molecular imaging by means of positron emission tomography (PET) were realized.     

Molecular Glue for RNA: Regulating RNA Structure and Function through Synthetic RNA Binding Molecules

We introduce the concept of molecular glues for RNA, in which specific RNA-binding small molecules induce designed structural changes in target functional RNAs, resulting in modulation of the functions. (Z)-NCTS is an RNA-mismatch-binding small molecule that recognizes 5′-r(XGG)-3′/5′-r(XGG)-3′ sequences (X=U or A) and acts as a molecular glue for RNA. The binding of (Z)-NCTS brings two distinct 5′-r(XGG)-3′ domains into contact with each other, and this can result in higher-order structural changes of target RNAs. We applied (Z)-NCTS to induce the formation of a proposed tertiary structure of a ribozyme together with activation of RNA-cleaving ability. The concept of a molecular glue could inspire new small-molecule-based strategies for regulating biological functions: a synthetic small molecule targeting functional RNAs could regulate the RNA structure and function.     

DNA Origami‐Enabled Engineering of Ligand–Drug Conjugates for Targeted Drug Delivery

Effective drug delivery systems that can systematically and selectively transport payloads to disease cells remain a challenge. Here, a targeting ligand‐modified DNA origami nanostructure (DON) as an antibody–drug conjugate (ADC)‐like carrier for targeted prostate cancer therapy is reported. Specifically, DON of six helical bundles is modified with a ligand 2‐[3‐(1,3‐dicarboxy propyl)‐ureido] pentanedioic acid (DUPA) against prostate‐specific membrane antigen (PSMA), to serve as the antibody for drug conjugation in ADC. Doxorubicin (Dox) is then loaded to DON through intercalation to dsDNA. This platform features in spatially controllable organization of targeting ligands and high drug loading capacity. With this nanocomposite, selective delivery of Dox to the PSMA+ cancer cell line LNCaP is readily achieved. The consequent therapeutic efficacy is critically dependent on the numbers of targeting ligand assembled on DON. This target‐specific and biocompatible drug delivery platform with high maximum tolerated doses shows immense potential for developing novel nanomedicine.     

High throughput screening of Monophos instant ligand library leads to a ton-scale asymmetric hydrogenation process

The development of catalytic processes for pharmaceuticals intermediates is often under severe time-pressure. To cope with this constraint, high throughput experimentation (HTE) methods have been implemented for catalyst finding. In this article, we present the HTE protocols put in place at DSM in the area of enantioselective hydrogenation. They mostly rely on libraries of monodentate chiral phosphoramidites ligands. We applied our instant ligand library technology to solve a real-life case, i.e. the asymmetric hydrogenation of an α-substituted cinnamic acid derivative. This has led to a multi-ton scale process.     

含手性膦配体MBPA和邻巯基吡啶配体PyS的过渡金属钯(Ⅱ)化合物的2D NMR研究

利用一维和二维NMR技术,对含手性膦配体MBPA和邻巯基吡啶配体PyS的过渡金属Pd(Ⅱ)化合物Pd(3-MBPA)(PyS)Cl)(1),Pd(2-MBPA)(PyS)Cl)(2)。进行~1H和~(13)C NMR谱分析,归属了所有的~1H和~(13)CNMR谱线,并对配体在配位前后的化学位移的变化作了简单讨论。     

Synthesis and characterization of resins with ligands containing guanidinine derivatives. Cu(II) sorption and coordination properties

A new modification direction of acrylonitrile, vinyl acetate and divinylbenzene terpolymers (A, B) are presented. The aminolysis of nitrile groups of the terpolymers using ethylenediamine or hydroxylamine hydrochloride was a first stage of the modification. The resulting amine groups reacted with dicyandiamide (DCDA), cyanamide (CA) and sodium dicyanimide (SDC) in order to obtain the biguanidyl, guanidyl or nitrilguanidyl derivatives in the polymer side chain, respectively. The properties of all obtained resin such as water regain, nitrogen content, amine and carboxyl group concentration and sorption properties towards Cu(II) from nitric acid solutions were determined. The studies of IR spectra of all the resins were performed. Structures of ligand complexes with Cu(II) were studied using electron paramagnetic resonance spectroscopy.     

核桃壳活性炭的制备及其对烟酸缓释性能的研究

以二氧化碳(CO2)物理活化法制备了核桃壳活性炭,考察了活化温度、活化时间对核桃壳活性炭得率及烟酸吸附量的影响。以所制备的核桃壳活性炭为烟酸载体,在不同的释放介质(蒸馏水、人工胃液或人工肠液)中进行烟酸释放性能研究。结果表明,人工胃液和人工肠液能促进活性炭对烟酸的释放,其累计释放率分别达到43.96%和47.69%。核桃壳活性炭在3种不同介质中的不同释放阶段的释放过程均符合Higuchi模型。